The New York Academy of Sciences
Insights into the Resolution of Inflammation
Posted February 25, 2020
Inflammation is a common feature of many widely occurring human diseases. In recent years, our understanding of the molecular mechanisms regulating inflammation has improved dramatically, most notably with the identification of active processes that control the resolution of the inflammatory response. Now, this rapidly evolving field of research – Resolution Pharmacology — promises novel approaches for the treatment of myriad inflammatory diseases. In this webinar, the first in a four-part series, leaders in the field explore recent research on the molecular mechanisms driving the resolution of inflammation and approaches to therapeutically target these pathways in chronic inflammatory and autoimmune diseases.
In This Webinar, You’ll Learn
- The key steps required for the successful resolution of inflammation.
- How pro-resolving mediators, including lipoxins, resolvins, maresins, and protectins are biosynthesized and how they regulate resolution.
- How defects in resolution pathways contribute to chronic autoimmune and inflammatory conditions.
- Emerging strategies to therapeutically target the resolution of inflammation in diabetes and its associated complications including atherosclerosis, kidney disease, and fibrosis.